- R&D collaboration to deliver a new single, fixed-dose combination therapy, significantly increasing the potential to treat patients in endemic countries - Paris, July 8, 2015 - Sanofi announced ...
MUNICH, January 16, 2026--(BUSINESS WIRE)--Circus SE (GSIN: A2YN35 / Symbol: CA1), a global AI robotics company, is expanding its offering with a leasing model in partnership with MMV Leasing GmbH, a ...
Genzyme Corporation and Medicines for Malaria Venture Announce New Collaboration with Advinus Therapeutics to Accelerate Discovery of Novel Therapies for Malaria Brings complementary capabilities in ...
CAMBRIDGE, Mass. and ABU DHABI, United Arab Emirates — Medicines for Malaria Venture (MMV), Genzyme Corp., and the Broad Institute of MIT and Harvard announced today that they have expanded their ...
AN3661 originates from organizations’ ongoing partnership to discover boron-based antimalarials. Medicines for Malaria Venture (MMV) and Anacor Pharmaceuticals are partnering on development of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results